Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Operating Expenses | 1,037 | 1,903 | 1,274 | 5,474 | 2,323 |
Operating Income | -1,037 | -1,903 | -1,274 | -5,474 | -2,323 |
Other Income | 9 | 15 | 32 | 59 | 81 |
Pre-tax Income | -1,028 | -1,888 | -1,242 | -5,415 | -2,242 |
Net Income Continuous | -1,028 | -1,888 | -1,242 | -5,415 | -2,242 |
Net Income | $-1,028 | $-1,888 | $-1,242 | $-5,415 | $-2,242 |
EPS Basic Total Ops | -67.64 | -124.00 | -90.18 | -293.09 | -157.82 |
EPS Basic Continuous Ops | -70.15 | -129.18 | -84.98 | -296.52 | -154.33 |
EPS Diluted Total Ops | -67.64 | -124.00 | -90.18 | -293.09 | -157.82 |
EPS Diluted Continuous Ops | -70.15 | -129.18 | -84.98 | -296.52 | -154.33 |
EBITDA(a) | $-1,037 | $-1,903 | $-1,274 | $-5,474 | $-2,323 |